Point of Care Diagnostics Market by Kits Product (Glucose Monitoring, Infectious Disease Testing, Pregnancy And Fertility Testing, Hematology Testing, Cardiometabolic Monitoring, Urinalysis Testing, Coagulation Monitoring, Tumor Markers Testing, Cholesterol Test Strips, Drugs Of Abuse Testing, Fecal Occult Testing) - Global Opportunity Analysis and Industry Forecasts, 2014 - 2022 Update Available On-Demand
|
A00080
|
Pages: 145
|
Oct
2016 |
20467 Views
|
|
|
|
Author(s) :
Sachin Sinha
|
Tables: 62
|
Charts: 65
|
Formats*:
|
|
Point Of Care Diagnostics Market Opportunities and Technology Trends:
The Global Point Of Care Diagnostics Market size was valued for $22,975 million in 2015 and is expected to reach $43,336 million by 2022, growing at a CAGR of 9.4% from 2016 to 2022. The point of care (POC) diagnostics defined in this report are the medical devices used to get an immediate result in the investigation (diagnosis & monitoring) of various diseases such as cancer, diabetes, cardiac diseases, and others.
This report covers information on various types of point of care diagnostic devices that are manufactured for medical purposes in compliance with the European Medical Association (EMA), the U.S. Food and Drugs Administration (FDA), Conformité Européene (CE) and other regulatory authorities. These devices include point of care testing devices, such as glucose monitoring kits, infectious diseases testing kits, pregnancy, and fertility testing kits, hematology testing kits, cardiometabolic monitoring kits, urinalysis testing kits, coagulation monitoring kits, tumor/cancer markers, cholesterol test strips, drugs of abuse testing kits, and fecal occult testing kits. These point of care diagnostics are used in healthcare facilities (professional diagnostic centers and research laboratories) as well as at home. Moreover, this study on the global point of care diagnostics market also focuses on the prescription mode of point of care diagnostic devices. By prescription mode, the market is segmented into prescription-based testing market and over-the-counter (OTC) testing market. The global point of care diagnostics market is segmented on the basis of product, end-user, mode of prescription, and geography.
The glucose monitoring kit segment dominates in the global POC diagnostics market. Glucose monitoring devices are used to measure the amount of glucose or sugar level in the blood stream. These devices provide reliable results, which can be used during routine check-ups to interpret risk factors with high sugar and also help in the designing of new diet chart& medications.
Increasing usage of home-based glucose monitoring systems is one of the key trends observed in the point of care diagnostics industry. Several companies are launching innovative and advanced glucose monitoring systems that have increased their adoption rate among the end-users. For instance, Abbott received approval from the Therapeutic Goods Administration (TGA) in Australia for its FreeStyle Libre Flash Glucose Monitoring System, a glucose sensing technology for insulin-using Australians suffering from diabetes.
Outpatient healthcare settings include retail clinics, hospital-based outpatient clinics, non-hospital based clinics, and physician offices, dental offices, home health care agencies, and hospices. These healthcare settings provide various types of outpatient services such as check-up, immediate treatment, and free check-up campaigns. To provide such service the physicians or healthcare professionals have to take help of diagnostic tests results, POC devices provide such results in a short time, and hence their demand is increasing among the outpatient healthcare settings.
Increasing prevalence of various chronic and infectious diseases across the world
Increase in prevalence of various chronic and infectious diseases such as cardiac diseases, hepatitis, cancer, gastrointestinal, respiratory, and sexually transmitted diseases (STDs) play a pivotal role in the growth of the global point of care diagnostics market share. Moreover, changes in life style patterns also cause several medical conditions, such as diabetes, hypertension, and obesity, which require point of care diagnostics devices for their diagnosis & monitoring.
For instance, according to the American Heart Association, cardiac diseases are one of the leading causes of death worldwide, accounting for 17.3 million deaths per year and projected to grow over 23.6 million by 2030.
Similarly, according to the World Health Organization (WHO), in 2012, 14.1 million new cases of cancer were reported and are expected to reach 15.5 million by 2030. Thus, this increase in prevalence of various chronic and infectious diseases fuels the demand for POC diagnostic devices and thus will drive the point of care diagnostics market growth.
According to the International Diabetes Federation (IDF), developing countries, such as India and China, are expected to have the highest number of diabetes mellitus patients compared to developed countries, such as U.S. and Germany. The number of patients with diabetes mellitus is expected to reach 87 million in India and 62.6 million in China compared to 36 million in U.S. by 2030. This increase in incidence of various diseases in various parts of the world is expected to drive the POC diagnostic procedures.
KEY BENEFITS
-
The study provides an in-depth analysis of the global industry with current POC diagnostics market trends and future estimations to elucidate the imminent investment pockets in the market
-
The report provides a quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on prevailing market opportunities
-
Extensive analysis of the global POC diagnostics market, by product, explains various types of devices used in the diagnosis of various diseases
-
Competitive intelligence highlights the business practices followed by leading market players across different geographical regions
Key market players within the point of care diagnostics market are profiled in this report and their strategies are analyzed thoroughly, which predicts the competitive outlook of global POC diagnostics market.
POINT OF CARE DIAGNOSTICS MARKET KEY SEGMENTS
BY PRODUCT
-
Glucose monitoring kits
-
Infectious disease testing kits
-
Hepatitis testing kits
-
HIV testing kits
-
Respiratory infections testing kits
-
Influenza testing kits
-
Healthcare-associated infections (HAIs) testing kits
-
Sexually-transmitted diseases (STDs) testing kits
-
Others
-
-
Pregnancy and fertility testing kits
-
Pregnancy testing kits
-
Fertility Testing Kits
-
-
Hematology testing kits
-
Cardiometabolic monitoring kits
-
Cardiac Markers Kits
-
HbA1c Testing Kits
-
Electrolytes Testing Kits
-
Others
-
-
Urinalysis Testing Kits
-
Coagulation Monitoring Kits
-
Tumor/Cancer Markers Testing Kits
-
Cholesterol Test Strips
-
Drugs of Abuse Testing Kits
-
Fecal Occult Testing Kits
-
Others (Calcium Assay Kits and Immunochemistry Kits)
BY END USER
-
Professional diagnostic centers
-
Hospitals/critical care centers
-
Outpatient healthcare Setting
-
Ambulatory care settings
-
-
Research laboratories
-
Home
-
Others (Medical universities, Not-for-profit organizations, and Nursing homes)
BY MODE OF PRESCRIPTION
-
Prescription based point of care diagnostics
-
Over-the-counter (OTC) based point of care testing devices
BY GEOGRAPHY
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
Germany
-
France
-
U.K.
-
Italy
-
Spain
-
Rest of Europe
-
-
Asia-Pacific
-
Japan
-
China
-
India
-
Australia
-
Rest of Asia-Pacific
-
-
LAMEA
-
Others
-
UAE
-
Brazil
-
CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Porters five forces analysis
3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Intensity of rivalry
3.3.5 Threat of substitutes
3.4 Market dynamics
3.4.1 Drivers
3.4.1.1 Increasing prevalence of chronic and infectitous diseases
3.4.1.2 Initiatives implemented by government and not-for-profit associations for rising health awareness
3.4.1.3 Technological Advancements and adoption of home-based point of care devices
3.4.1.4 Increasing healthcare expenditures worldwide
3.4.2 Restraints
3.4.2.1 Stringent regulatory requirements for the approval and commercialization of point of care diagnostic devices
3.4.2.2 Inadequate reimbursement policies for point of care diagnostic devices
3.4.3 Opportunities
3.4.3.1 Developing economies offer lucarative growth opportunities
CHAPTER 4 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY PRODUCT
4.1 Overview
4.2 Glucose monitoring kits
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.3 Infectious diseases testing kits
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.3.4 Hepatitis testing kits
4.3.4.1 Market size and forecast
4.3.5 HIV testing kits
4.3.5.1 Market size and forecast
4.3.6 Respiratory infections testing kits
4.3.6.1 Market size and forecast
4.3.7 Influenza testing kits
4.3.7.1 Market size and forecast
4.3.8 Healthcare-associated infections (HAIs) testing kits
4.3.8.1 Market size and forecast
4.3.9 Sexually-transmitted diseases (STDs) testing kits
4.3.9.1 Market size and forecast
4.3.10 Other infectious disease point of care testing kits
4.3.10.1 Market size and forecast
4.4 Pregnancy and fertility testing kits
4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
4.4.4 Pregnancy testing kits
4.4.4.1 Market size and forecast
4.4.5 Fertility testing kits
4.4.5.1 Market size and forecast
4.5 Hematology testing kits
4.5.1 Key market trends
4.5.2 Key growth factors and opportunities
4.5.3 Market size and forecast
4.6 Cardiometabolic monitoring kits
4.6.1 Key market trends
4.6.2 Key growth factors and opportunities
4.6.3 Market size and forecast
4.6.4 Cardiac markers test kits
4.6.4.1 Market size and forecast
4.6.5 HbA1c testing kits
4.6.5.1 Market size and forecast
4.6.6 Electrolytes and metabolites testing kits
4.6.6.1 Market size and forecast
4.7 Urinalysis testing devices
4.7.1 Key market trends
4.7.2 Key growth factors and opportunities
4.7.3 Market size and forecast
4.8 Coagulation monitoring kits
4.8.1 Key market trends
4.8.2 Key growth factors and opportunities
4.8.3 Market size and forecast
4.9 Tumor or cancer markers testing devices
4.9.1 Key market trends
4.9.2 Key growth factors and opportunities
4.9.3 Market size and forecast
4.10 Cholesterol testing strips
4.10.1 Key market trends
4.10.2 Key growth factors and opportunities
4.10.3 Market size and forecast
4.11 Drugs of abuse testing kits
4.11.1 Key market trends
4.11.2 Key growth factors and opportunities
4.11.3 Market size and forecast
4.12 Fecal occult testing kits
4.12.1 Key market trends
4.12.2 Key growth factors and opportunities
4.12.3 Market size and forecast
4.13 Other point of care testing devices
4.13.1 Key market trends
4.13.1 Key growth factors and opportunities
4.13.2 Market size and forecast
CHAPTER 5 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY END USER
5.1 Overview
5.1.1 Market size and forecast
5.2 Professional diagnostic centers
5.2.1 Market size and forecast
5.2.2 Hospitals/critical care centers
5.2.2.1 Market size and forecast
5.2.3 Outpatient healthcare settings
5.2.3.1 Market size and forecast
5.2.4 Ambulatory care settings
5.2.4.1 Market size and forecast
5.3 Research laboratories
5.3.1 Market size and forecast
5.4 Home
5.4.1 Market size and forecast
5.5 Others
5.5.1 Market size and forecast
CHAPTER 6 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY MODE OF PRESCRIPTION
6.1 Introduction
6.2 Prescription based testing devices
6.2.1 Market size and forecast
6.3 Over-the-counter (OTC) testing devices
6.3.1 Market size and forecast
CHAPTER 7 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2015-2022
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast
7.2.4 U.S. market size and forecast
7.2.5 Canada market size and forecast
7.2.6 Mexico market size and forecast
7.3 Europe
7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast
7.3.4 Germany market size and forecast
7.3.5 France market size and forecast
7.3.6 U.K.
7.3.6.1 Market size and forecast
7.3.7 Italy
7.3.7.1 Market size and forecast
7.3.8 Spain
7.3.8.1 Market size and forecast
7.3.9 Rest of Europe
7.3.9.1 Market size and forecast
7.4 Asia-Pacific
7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast
7.4.4 Japan
7.4.4.1 Market size and forecast
7.4.5 China
7.4.5.1 Market size and forecast
7.4.6 India
7.4.6.1 Market size and forecast
7.4.7 Rest of Asia-Pacific
7.4.7.1 Market size and forecast
7.5 LAMEA
7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast
7.5.4 Brazil
7.5.4.1 Market size and forecast
7.5.5 UAE
7.5.5.1 Market size and forecast
7.5.6 Rest of LAMEA
7.5.6.1 Market size and forecast
CHAPTER 8 COMPANY PROFILES
8.1 Abbott Laboratories
8.1.1 Company overview
8.1.2 Operating business segments
8.1.3 Business performance
8.1.4 Key strategic moves & developments
8.2 Siemens AG
8.2.1 Company overview
8.2.2 Operating business segments
8.2.3 Business performance
8.2.4 Key strategic moves & developments
8.3 F. Hoffmann-La Roche Ltd
8.3.1 Company overview
8.3.2 Operating business segments
8.3.3 Business performance
8.3.4 Key strategic moves & developments
8.4 Sinocare Inc.
8.4.1 Company overview
8.4.2 Operating business segments
8.4.3 Business performance
8.4.4 Key strategic moves & developments
8.5 Johnson & Johnson
8.5.1 Company overview
8.5.2 Operating business segments
8.5.3 Business performance
8.5.4 Key strategic moves & developments
8.6 Sysmex Corporation
8.6.1 Company overview
8.6.2 Operating product categories
8.6.3 Business performance
8.6.4 Key strategic moves & developments
8.7 Nova Biomedical
8.7.1 Company overview
8.7.2 Operating business segments
8.7.3 Business performance
8.7.4 Key strategic moves & developments
8.8 Danaher Corporation
8.8.1 Company overview
8.8.2 Operating business segments
8.8.3 Business performance
8.8.4 Key strategic moves & developments
8.9 Becton Dickinson and Company
8.9.1 Company overview
8.9.2 Business performance
8.9.3 Key strategies and development
8.10 bioMrieux SA
8.10.1 Company overview
8.10.2 bioMerieux - COMPANY SNAPSHOT
8.10.3 Operating business segments
8.10.4 Business performance
8.10.5 Key strategic moves & developments
8.11 Bio-Rad Laboratories
8.11.1 Company overview
8.11.2 Operating business segments
8.11.3 Business performance
8.11.4 Key strategic moves & developments
List of Figures
FIG. 1 TOP INVESTMENT POCKETS IN WORLD DEFIBRILLATORS MARKET
FIG. 2 TOP WINNING STRATEGIES PERCENTAGE DISTRIBUTION, 20142016
FIG. 3 PORTERS FIVE FORCES ANALYSIS
FIG. 4 TOP IMPACTING FACTORS WORLD POINT OF CARE DIAGNOSTICS MARKET
FIG. 5 PREVALENCE OF DIABETES MELLITUS (BETWEEN THE AGE GROUP OF 20 79 YEARS) IN MAJOR COUNTRIES, 2010 AND 2030 (MILLIONS)
FIG. 6 APPLICATIONS OF POINT OF CARE DIAGNOSTIC DEVICES
FIG. 7 MEDICAL DEVICE DEVELOPMENT AND APPROVAL PROCEDURE
FIG. 8 WORLD HEPATITIS TESTING KITSMARKET, 2014-2022 ($MILLION)
FIG. 9 WORLD HIV TESTING KITS MARKET, 2014-2022 ($MILLION)
FIG. 10 WORLD RESPIRATORY INFECTION TESTING KITS MARKET, 2014-2022 ($MILLION)
FIG. 11 WORLD INFLUENZA TESTING KITS MARKET, 2014-2022 ($MILLION)
FIG. 12 WORLD HAIS TESTING KITS MARKET, 2014-2022 ($MILLION)
FIG. 13 WORLD STDS TESTING KITSMARKET, 2014-2022 ($MILLION)
FIG. 14 WORLD OTHERS INFECTIOUS DISEASE TESTING KITS MARKET, 2014-2022 ($MILLION)
FIG. 15 WORLD PREGNANCY TESTING KITSMARKET, 2014-2022 ($MILLION)
FIG. 16 WORLD FERTILITY TESTING KITS MARKET, 2014-2022 ($MILLION)
FIG. 17 WORLD CARDIAC MARKERS TEST KITSMARKET, 2014-2022 ($MILLION)
FIG. 18 WORLD HBA1C TESTING KITSMARKET, 2014-2022 ($MILLION)
FIG. 19 WORLD ELECTROLYTES AND METABOLITES TESTING KITS MARKET, 2014-2022 ($MILLION)
FIG. 20 WORLD POINT OF CARE DIAGNOSTIC DEVICES FOR HOSPITALS/CRITICAL CARE CENTERS MARKET, 2014-2022 ($MILLION)
FIG. 21 WORLD POINT OF CARE DIAGNOSTIC DEVICES FOR OUTPATIENT HEALTHCARE SETTINGS MARKET, 2014-2022 ($MILLION)
FIG. 22 WORLD POINT OF CARE DIAGNOSTIC DEVICES FOR AMBULATORY CARE SETTINGS MARKET, 2014-2022 ($MILLION)
FIG. 23 U.S. POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 24 CANADA POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 25 MEXICO POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 26 GERMANY POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 27 FRANCE POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 28 U.K. POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 29 ITALY POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 30 SPAIN POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 31 REST OF EUROPE POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 32 JAPAN POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 33 CHINA POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 34 INDIA POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 35 REST OF ASIA-PACIFIC POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 36 BRAZIL POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 37 UAE POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 38 REST OF LAMEA POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 39 ABBOTT REVENUE, 2013-2015 ($MILLION)
FIG. 40 ABBOTT REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 41 ABBOTT REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 42 SIEMENS-REVENUE, 2013-2015 ($MILLION)
FIG. 43 SIEMENS-REVENUE BY INDUSTRIAL BUSINESS, 2015 (%)
FIG. 44 SIEMENS - REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 45 ROCHE-NET SALES, 2013-2015 ($MILLION)
FIG. 46 ROCHE- REVENUE, BY OPEARTING SEGMENTS 2015 (%)
FIG. 47 ROCHE NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 48 SINOCARE-REVENUE, 2013-2015 ($MILLION)
FIG. 49 JNJ REVENUE, 2013 2015 ($MILLION)
FIG. 50 JNJ- REVENUE, BY SEGMENT, 2015 (%)
FIG. 51 JNJ REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 52 SYSMEX REVENUE, 2013-2015 ($MILLION)
FIG. 53 SYSMEX REVENUEBY BUSINESS SEGMENT (2015)
FIG. 54 SYSMEX REVENUE BY GEOGRAPHY (2015)
FIG. 55 DANAHER:REVENUE, 2013-2015 ($MILLION)
FIG. 56 DANAHER OPERATING SEGMENT REVENUE, 2015 (%)
FIG. 57 DANAHER REVENUE GEOGRAPHY SEGMENT, 2015 (%)
FIG. 58 BD REVENUE, 2013-2015 ($MILLION)
FIG. 59 BD:REVENUE BY SEGMENT (2015)
FIG. 60 BD:REVENUE BY GEOGRAPHY (2015)
FIG. 61 BIOMERIEUX -REVENUE, 2013-2015 ($MILLION)
FIG. 62 BIOMERIEUX, % NET SALES BY GEOGRAPHY (2015)
FIG. 63 BIO-RAD-NET SALES, 2013-2015 ($MILLION)
FIG. 64 BIO-RAD:REVENUEBY OPERATING SEGMENT, 2015 (%)
FIG. 65 BIO RAD REVENUE BY GEOGRAPHY (2015)
List of Tables
TABLE 1 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 2 WORLD GLUCOSE MONITORING KITS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 3 WORLD INFECTIOUS DISEASES TESTING KITSMARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 4 WORLD INFECTIOUS DISEASES TESTING KITSMARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 5 WORLD PREGNANCY AND FERTILITY TESTING KITS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 6 WORLD PREGNANCY AND FERTILITY TESTING KITS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 7 WORLD HEMATOLOGY TESTING KITS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 8 WORLD CARDIOMETABOLIC MONITORING KITS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 9 WORLD CARDIOMETABOLIC MONITORING KITS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 10 WORLD URINALYSIS TESTING KITS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 11 WORLD COAGULATION MONITORING KITS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 12 WORLD TUMOR OR CANCER MARKER TESTING KITS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 13 WORLD CHOLESTEROL TESTING STRIPS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 14 WORLD DRUGS OF ABUSE TESTING KITSMARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 15 WORLD FECAL OCCULT TESTING KITS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 16 WORLD OTHER POINT OF CARE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 17 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY END USER, 2014-2022, ($MILLION)
TABLE 18 WORLD POINT OF CARE DIAGNOSTICS MARKET FOR PROFESSIONAL DIAGNOSTIC CENTERS, BY TYPE, 2014-2022 ($MILLION)
TABLE 19 WORLD POINT OF CARE DIAGNOSTICS MARKET FOR PROFESSIONAL DIAGNOSTIC CENTERS, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 20 WORLD POINT OF CARE DIAGNOSTICS MARKET FOR RESEARCH LABORATORIES, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 21 WORLD POINT OF CARE DIAGNOSTICS MARKET FOR HOME END USER, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 22 WORLD POINT OF CARE DIAGNOSTICS MARKET FOR OTHER END USER, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 23 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY MODE OF PRESCRIPTION, 2014-2022 ($MILLION)
TABLE 24 WORLD PRESCRIPTION BASED POINT OF CARE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 25 WORLD OTC BASED POINT OF CARE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 26 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 27 NORTH AMERICA:POINT OF CARE DIAGNOSTICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 28 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 29 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 30 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET, BY MODE OF PRESCRIPTION, 2014-2022 ($MILLION)
TABLE 31 EUROPE POINT OF CARE DIAGNOSTICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 32 EUROPE POINT OF CARE DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 33 EUROPE POINT OF CARE DIAGNOSTICS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 34 EUROPE POINT OF CARE DIAGNOSTICS MARKET, BY MODE OF PRESCRIPTION, 2014-2022 ($MILLION)
TABLE 35 ASIA-PACIFIC POINT OF CARE DIAGNOSTICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 36 ASIA- PACIFIC POINT OF CARE DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 37 ASIA- PACIFIC POINT OF CARE DIAGNOSTICS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 38 ASIA- PACIFIC POINT OF CARE DIAGNOSTICS MARKET, BY MODE OF PRESCRIPTION, 2014-2022 ($MILLION)
TABLE 39 LAMEA POINT OF CARE DIAGNOSTICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 40 LAMEA POINT OF CARE DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 41 LAMEA POINT OF CARE DIAGNOSTICS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 42 LAMEA POINT OF CARE DIAGNOSTICS MARKET, BY MODE OF PRESCRIPTION, 2014-2022 ($MILLION)
TABLE 43 ABBOTTCOMPANY SNAPSHOT
TABLE 44 ABBOTT - OPERATING SEGMENTS
TABLE 45 SIEMENS AG - COMPANY SNAPSHOT
TABLE 46 SIEMENS - OPERATING SEGMENTS
TABLE 47 ROCHECOMPANY SNAPSHOT
TABLE 48 ROCHE - OPERATING SEGMENTS
TABLE 49 SINOCARECOMPANY SNAPSHOT
TABLE 50 SINOCAREOPERATING SEGMENTS
TABLE 51 JNJCOMPANY SNAPSHOT
TABLE 52 JNJ- OPERATING SEGMENTS
TABLE 53 SYSMEX - COMPANY SNAPSHOT
TABLE 54 SYSMEXPRODUCT CATEGORIES
TABLE 55 NOVA BIOMEDICALCOMPANY SNAPSHOT
TABLE 56 NOVA BIOMEDICAL - OPERATING SEGMENTS
TABLE 57 DANAHERCOMPANY SNAPSHOT
TABLE 58 DANAHER- OPERATING SEGMENTS
TABLE 59 BDSNAPSHOT
TABLE 60 BIOMRIEUX - OPERATING SEGMENTS
TABLE 61 BIO-RADCOMPANY SNAPSHOT
TABLE 62 BIO-RAD - OPERATING SEGMENTS
Download Sample
Purchase Full Report of
Point of Care Diagnostics Market- Global Opportunity Analysis and Industry Forecasts, 2014 - 2022
- Online Only
- $3,565
- Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
- $3,961
- Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
- $5,540
- Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
- $6,654
- Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF - $9,280
- Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Library Membership
- $0.00
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading instantly.
Buy Now
This title and over 12,000+ are available on the Avenue Library. Subscription @ $699 T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.